Geographical Location stringclasses 54
values | Report Date stringclasses 1
value | MDS Item Question/Description stringclasses 828
values | MDS Item Response stringclasses 303
values | Percent stringlengths 1 5 | Total Residents stringlengths 1 7 |
|---|---|---|---|---|---|
Idaho | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | No | * | * |
Idaho | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | Yes | * | * |
Illinois | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | No | 90.71 | 244 |
Illinois | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | Yes | 9.29 | 25 |
Indiana | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | No | 95.24 | 100 |
Indiana | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | Yes | * | * |
Iowa | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | No | 90.7 | 39 |
Iowa | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | Yes | * | * |
Kansas | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | No | 88.37 | 38 |
Kansas | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | Yes | * | * |
Kentucky | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | No | 91.55 | 65 |
Kentucky | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | Yes | * | * |
Louisiana | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | No | 91.95 | 80 |
Louisiana | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | Yes | * | * |
Maine | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | No | * | * |
Maine | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | Yes | * | * |
Maryland | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | No | 93.22 | 110 |
Maryland | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | Yes | * | * |
Massachusetts | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | Yes | 10.42 | 15 |
Massachusetts | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | No | 89.58 | 129 |
Michigan | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | No | 92.91 | 118 |
Michigan | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | Yes | * | * |
Minnesota | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | No | 88.1 | 37 |
Minnesota | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | Yes | * | * |
Mississippi | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | Yes | * | * |
Mississippi | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | No | 93.94 | 62 |
Missouri | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | Yes | * | * |
Missouri | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | No | 89.89 | 80 |
Montana | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | No | * | * |
Montana | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | Yes | * | * |
Nebraska | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | No | 84 | 21 |
Nebraska | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | Yes | * | * |
Nevada | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | No | 100 | 20 |
Nevada | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | Yes | * | * |
New Hampshire | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | No | 100 | 16 |
New Hampshire | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | Yes | * | * |
New Jersey | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | No | 90.75 | 265 |
New Jersey | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | Yes | 9.25 | 27 |
New Mexico | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | No | 100 | 16 |
New Mexico | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | Yes | * | * |
New York | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | Yes | 6.49 | 34 |
New York | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | No | 93.51 | 490 |
North Carolina | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | No | 83.64 | 92 |
North Carolina | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | Yes | 16.36 | 18 |
North Dakota | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | No | * | * |
North Dakota | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | Yes | * | * |
Ohio | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | Yes | 14.49 | 30 |
Ohio | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | No | 85.51 | 177 |
Oklahoma | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | No | 85.19 | 46 |
Oklahoma | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | Yes | * | * |
Oregon | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | No | 88.24 | 15 |
Oregon | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | Yes | * | * |
Pennsylvania | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | Yes | 7.25 | 14 |
Pennsylvania | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | No | 92.75 | 179 |
Puerto Rico | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | No | * | * |
Puerto Rico | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | Yes | * | * |
Rhode Island | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | Yes | * | * |
Rhode Island | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | No | * | * |
South Carolina | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | No | 94.92 | 56 |
South Carolina | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | Yes | * | * |
South Dakota | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | Yes | * | * |
South Dakota | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | No | 100 | 11 |
Tennessee | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | No | 95.56 | 86 |
Tennessee | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | Yes | * | * |
Texas | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | No | 90.91 | 210 |
Texas | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | Yes | 9.09 | 21 |
Utah | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | No | * | * |
Utah | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | Yes | * | * |
Vermont | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | No | * | * |
Vermont | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | Yes | * | * |
Virgin Islands | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | No | * | * |
Virgin Islands | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | Yes | * | * |
Virginia | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | No | 86.73 | 85 |
Virginia | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | Yes | 13.27 | 13 |
Washington | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | No | 95.92 | 47 |
Washington | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | Yes | * | * |
West Virginia | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | Yes | * | * |
West Virginia | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | No | 86.36 | 19 |
Wisconsin | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | No | 91.07 | 51 |
Wisconsin | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | Yes | * | * |
Wyoming | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | No | * | * |
Wyoming | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | Yes | * | * |
National Total | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | No | 90.6 | 4224 |
National Total | Q1, 2025 | A2122B: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Health Information Exchange | Yes | 9.4 | 438 |
Alabama | Q1, 2025 | A2122C: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Verbal (e.g., in-person, telephone, video conferencing) | Yes | 42.37 | 25 |
Alabama | Q1, 2025 | A2122C: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Verbal (e.g., in-person, telephone, video conferencing) | No | 57.63 | 34 |
Alaska | Q1, 2025 | A2122C: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Verbal (e.g., in-person, telephone, video conferencing) | Yes | * | * |
Alaska | Q1, 2025 | A2122C: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Verbal (e.g., in-person, telephone, video conferencing) | No | * | * |
Arizona | Q1, 2025 | A2122C: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Verbal (e.g., in-person, telephone, video conferencing) | Yes | 44.74 | 17 |
Arizona | Q1, 2025 | A2122C: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Verbal (e.g., in-person, telephone, video conferencing) | No | 55.26 | 21 |
Arkansas | Q1, 2025 | A2122C: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Verbal (e.g., in-person, telephone, video conferencing) | No | 48.57 | 17 |
Arkansas | Q1, 2025 | A2122C: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Verbal (e.g., in-person, telephone, video conferencing) | Yes | 51.43 | 18 |
California | Q1, 2025 | A2122C: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Verbal (e.g., in-person, telephone, video conferencing) | Yes | 56.56 | 306 |
California | Q1, 2025 | A2122C: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Verbal (e.g., in-person, telephone, video conferencing) | No | 43.44 | 235 |
Colorado | Q1, 2025 | A2122C: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Verbal (e.g., in-person, telephone, video conferencing) | Yes | 52.17 | 12 |
Colorado | Q1, 2025 | A2122C: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Verbal (e.g., in-person, telephone, video conferencing) | No | 47.83 | 11 |
Connecticut | Q1, 2025 | A2122C: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Verbal (e.g., in-person, telephone, video conferencing) | No | 73.97 | 54 |
Connecticut | Q1, 2025 | A2122C: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Verbal (e.g., in-person, telephone, video conferencing) | Yes | 26.03 | 19 |
Delaware | Q1, 2025 | A2122C: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Verbal (e.g., in-person, telephone, video conferencing) | Yes | 66.67 | 14 |
Delaware | Q1, 2025 | A2122C: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Verbal (e.g., in-person, telephone, video conferencing) | No | * | * |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.